Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Delayed Graft Function and POR[original query] |
|---|
| Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. Therapeutic drug monitoring 2014 Feb 36 (1): 71-9. Elens Laure, Hesselink Dennis A, Bouamar Rachida, Budde Klemens, de Fijter Johannes W, De Meyer Martine, Mourad Michel, Kuypers Dirk R J, Haufroid Vincent, van Gelder Teun, van Schaik Ron H |
| Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. Pharmacogenetics and genomics 2014 Dec 24 (12): 597-606. Kuypers Dirk R J, de Loor Henriette, Naesens Maarten, Coopmans Tamara, de Jonge Hyl |
| Association of CYP3A variants with kidney transplant outcomes. Renal failure 2015 May 37 (4): 562-6. Traynor Carol, Conlon Peter, Phelan Paul J, O'Kelly Patrick, Elens Laure, McCormack Mark, Cavalleri Gianpiero, Comber Harry, van Schaik R H N, Conlon Peter |
| Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation. Pharmacogenetics and genomics 2018 11 29 (1): 9-17. Hu Rong, Barratt Daniel T, Coller Janet K, Sallustio Benedetta C, Somogyi Andrew |
| CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics 2019 12 21 (1): 7-21. Genvigir Fabiana Dalla Vecchia, Campos-Salazar Antony Brayan, Felipe Claudia Rosso, Tedesco-Silva Helio, Medina-Pestana José Osmar, Doi Sonia de Quateli, Cerda Alvaro, Hirata Mario Hiroyuki, Herrero María José, Aliño Salvador Francisco, Hirata Rosario Dominguez Cres |
- Page last reviewed:Feb 1, 2024
- Content source: